Universal Ibogaine Inc (TSE:IBO) has released an update.
Universal Ibogaine Inc. is set to raise $600,000 through a non-brokered private placement of 30 million shares at $0.02 each, pending TSX Venture Exchange approval. The funds are earmarked for Health Canada’s ibogaine-based clinical trial application process and general corporate purposes, following a recent private placement that attracted considerable investor interest. The company specializes in pioneering addiction treatment protocols using ibogaine, aiming to significantly improve addiction recovery outcomes.
For further insights into TSE:IBO stock, check out TipRanks’ Stock Analysis page.
